U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07423650) titled 'Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy' on Feb. 04.
Brief Summary: The goal of this clinical trial is to determine whether continuous nefopam administration, as part of a multimodal analgesia strategy, reduces opioid consumption and improves patient satisfaction after pancreatoduodenectomy.
The main questions are:
Does nefopam administration reduce opioid consumption after pancreatoduodenectomy?
Does nefopam administration reduce postoperative pain levels after pancreatoduodenectomy?
Researchers will compare two other analgesic strategies, namely continuous lidocaine infusion and epidural ana...